SCHEMBL4120889

SCHEMBL4120889

COc1ccc2nc(C)c3c(C)nc(-c4cc(C(N)=O)ccc4F)n3c2n1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 20/20 0.68
PDE2A O00408 17/20 0.68
PDE7A Q13946 5/20 0.68
PDE5A O76074 3/20 0.68
PDE11A Q9HCR9 2/20 0.68
PDE3A Q14432 2/20 0.53
PDE6D O43924 1/20 0.53
PDE6A P16499 1/20 0.53
PDE6G P18545 1/20 0.53
PDE4A P27815 1/20 0.53
PDE6B P35913 1/20 0.53
PDE6C P51160 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53
PDE3B Q13370 1/20 0.53
PDE6H Q13956 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4105573 0.91 PDE10A (0.62) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL3996062 0.90 PDE10A (0.58) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4286788 0.88 PDE10A (0.56) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4135798 0.85 PDE10A (0.51) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4113292 0.84 PDE10A (0.65) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4120465 0.83 PDE10A (0.77) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4122787 0.82 PDE10A (0.68) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4117749 0.82 PDE10A (0.74) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL969664 0.82 PDE10A (0.54) PDE10APDE2APDE7APDE5APDE11A
SCHEMBL4116899 0.81 PDE10A (1.00) PDE10APDE2APDE7APDE5APDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070583-A1 PYRIDO[3,2-E]PYRAZINES, PROCESS FOR PREPARING THE SAME, AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10 WYETH (US) 2009-06-04 WO claimed
US-20090143361-A1 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 ELBION GMBH (DE) 2009-06-04 US claimed
WO-2009070583-A1 PYRIDO[3,2-E]PYRAZINES, PROCESS FOR PREPARING THE SAME, AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10 WYETH (US) 2009-06-04 WO disclosed
US-20090143361-A1 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 ELBION GMBH (DE) 2009-06-04 US disclosed
US-20090143361-A1 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 ELBION GMBH (DE) 2009-06-04 US disclosed
US-20090143361-A1 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 ELBION GMBH (DE) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143361-A1 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 PDE12, PDE5A, PDE3A PDE10A 10/4885PDE2A 4/4885PDE7A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.